Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study

Clinical trial NCT03244176 · UNKNOWN

Trial details

NCT number: NCT03244176
Sponsor: Austin Health
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lymphomas Non-Hodgkin's B-Cell

Start date: 2017-07-21
Primary completion: 2022-06-16
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.